Chemicalinfo Chemlink Pharm-Chem Net

Roche vs Cipla: Will the Real Price of "Tarceva" Please Show Up?Last Thursday, Arun Jaitley finally wound up his arguments on behalf of Cipla. A very impressive performance and I can see why Cipla won relatively easily at the first insta...

FDA MedWatch - July 2008 Drug Safety-Related Labeling Changes for 35 Drugs Now Available on Web  The July 2008 posting includes 35 drug products with safety labeling changes to the following sections: BOXED WARNING, CONTRAINDICATIONS, WARN...

The targeted agent Sutent® (sunitinib) provides superior quality of life compared with interferon alfa for patients with advanced renal cell carcinoma (RCC). These results were recently published in the August 1, 208 issue of Journal of Clinical Oncology.

All About Lung CancerDescription of Lung CancerLung cancer is the number one cause of cancer deaths among men and women in the United States. There are two major types of lung cancer: small cell and non-small cell. Non-small cell makes up about 80 to...

DSM and MorphoSys add MOR202 to Ab dealBy Gareth Macdonald14-Aug-2008 - US-based DSM Biologics and MorphoSys are teaming up to manufacture the MOR202 antibody, which has shown considerable promise as a treatment for multiple myeloma (MM).The agent, w...

Siemens building radiopharma sites in IndiaBy Nick Taylor13-Aug-2008 - Siemens has outlined plans to establish itself as a leading provider of radiopharmaceuticals in India through the construction of numerous manufacturing facilities.The company has...

Study of Tipifarnib in Patients With High-Risk Myelodysplastic Syndrome (MDS)This study has been completed. Sponsored by: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. ...

Study of Tipifarnib as Postconsolidation Therapy for Acute Myeloid Leukemia in Patients 60 Years and OlderThis study has been completed. Sponsored by: Johnson & Johnson Pharmaceutical Research & Development...

Cancer drugs 'postcode lottery'SARAH BREALEY11 August 2008 17:15Access to the latest cancer drugs is a postcode lottery, according to research from a charity.In some areas of the country, every exceptional request for a cancer drug which is not u...

ARTICLES Ramelteon: A Novel Approach in the Treatment of Insomnia (CE) (September) Jill N Reynoldson PharmD1, Ellie SR Elliott PharmD BCPP2, Leigh Anne Nelson PharmD BCPP3* 1 Psychi...